Wyss Zürich Logo with claim Wyss Zürich Logo with claim
Wysszurich keyvisual somagenetix Voliro Exec Team Cherry Ventures news TOP100 Nanoflex Falling Walls Nanoflex Abb Sevensense Seervision Acquisition23 Wyss Annual Event 2023 177 All projects of Wyss Zurich Slider Vacancies

Somagenetix raises CHF 10M in 1st Series A closing

The financing round was led by Vi Partners. Among others, existing investors Schroders Capital, Zürcher Kantonalbank and Verve Ventures also participated to this financing round. The funds will enable Somagenetix to advance its lead gene therapy candidate into a clinical trial.

Voliro secures $12M in Series A funding round

Our alumni project closed the round, led by Cherry Ventures, with additional investment from existing business angels, family offices, and a conventional debt facility.

TOP 100: Wyss Zurich Highlights

Discover the world shapers of tomorrow.

Nanoflex : Finalist @ Falling Walls Global Venture

Nanoflex is in the running for the Science Breakthrough of the Year Award and will pitch at the Falling Walls Science Summit from 7-9 November 2024 in Berlin. (Photo credit: Falling Walls Foundation)

Sevensense acquired by ABB

Sevensense will continue its innovation in AI and 3D vision with ABB.

Seervision acquired by Q-SYS

Seervision joins forces with Q-SYS to bring together exceptional teams and expand intelligent collaboration solutions

Annual Event 2023

Impressions from our flagship event of the year!

26 Projects supported

with life changing impact in society and markets

We are hiring

Who we are

Wyss Zurich is a unique accelerator, embedded within the ETH Zurich and the University of Zurich, dedicated to the emerging fields of regenerative medicine and robotics, and medical devices/bionics technologies. We unite world-leading experts, pooling their knowledge and expertise, to form multidisciplinary teams.

News

Scirobotics ado3187 f1 14-10-2024

WIRED: Nanoflex as one of Zurich's hottest startups

What began as a student research project at the Multiscale Robotics Lab at ETH has now culminated into something larger and impactful for patients and healthcare.
Wysszurich keyvisual denovoskin 10-10-2024

CUTISS Announces First Reconstructive Surgery under Compassionate Use and First U.S. Patient Treated with denovoSkin™

In a compassionate reconstructive procedure, denovoSkin™ was grafted on a pediatric patient, marking the first use of denovoSkin™ in the U.S. and the first use of denovoSkin™ in such a surgery.
Wysszurich keyvisual somagenetix 08-10-2024

Somagenetix raises CHF 10M to advance its first gene therapy candidate into a clinical trial

Our current project, Somagenetix, recently announced the first closing of a successful Series A financing round. The funds will enable Somagenetix to advance its leading gene therapy-candidate,...
Organizational new

Organizational Setup

The Wyss Zurich Translational Center is run jointly by the ETH Zurich and University of Zurich, with infrastructure on both sides. The head office, technology platforms, and the projects are allocated at the Wyss Zurich Translational Center, which is the operational body. The Wyss Zurich Foundation is the approval and funding body.

Key Figures

26

Projects supported

700+

Jobs created

135 M+

(CHF) Total funding

350 M+

(CHF) Additional funding

Hansjoerg wyss gespraech 1400

Philanthropist Hansjörg Wyss

Hansjörg Wyss is a Swiss entrepreneur and philanthropist who dedicates his philanthropic activities to environmentalism, scientific research and translation. In Switzerland, his donations have already exceed more than half a billion Swiss Francs in less than ten years, to groundbreaking research projects within three different Wyss Centers or Academy in Zurich, Geneva, and Bern. This makes him the most generous private donor to the Swiss research and innovation landscape.